Patents by Inventor Richard Penson

Richard Penson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT METHODS USING ADENOVIRUS
    Publication number: 20220331383
    Abstract: The invention provides methods of reducing or decreasing a size of a tumor or eliminating a tumor or inhibiting, decreasing, or reducing neo-vascularization or angiogenesis in a tumor in a patient by administering an adenovirus comprising a nucleic acid construct comprising a FAS-chimera gene operably linked to an endothelial cell-specific promoter. Also provided is a homogeneous population of an adenovirus comprising a FAS-chimera gene operably linked to an endothelial cell-specific promoter and its uses thereof.
    Type: Application
    Filed: March 22, 2022
    Publication date: October 20, 2022
    Applicant: Vascular Biogenics Ltd.
    Inventors: Eyal BREITBART, Andrea LEUBITZ, Erez FEIGE, Richard PENSON
  • Treatment methods using adenovirus
    Patent number: 11311583
    Abstract: The invention provides methods of reducing or decreasing a size of a tumor or eliminating a tumor by inhibiting, decreasing, or reducing neo-vascularization or angiogenesis in a tumor in a patient by administering an adenovirus comprising a nucleic acid construct comprising a FAS-chimera gene operably linked to an endothelial cell-specific promoter. Also provided is a homogeneous population of an adenovirus comprising a FAS-chimera gene operably linked to an endothelial cell-specific promoter and its uses thereof.
    Type: Grant
    Filed: July 23, 2018
    Date of Patent: April 26, 2022
    Assignee: Vascular Biogenetics Ltd.
    Inventors: Eyal Breitbart, Andrea Leubitz, Erez Feige, Richard Penson
  • TREATMENT METHODS USING ADENOVIRUS
    Publication number: 20190054130
    Abstract: The invention provides methods of reducing or decreasing a size of a tumor or eliminating a tumor by inhibiting, decreasing, or reducing neo-vascularization or angiogenesis in a tumor in a patient by administering an adenovirus comprising a nucleic acid construct comprising a FAS-chimera gene operably linked to an endothelial cell-specific promoter. Also provided is a homogeneous population of an adenovirus comprising a FAS-chimera gene operably linked to an endothelial cell-specific promoter and its uses thereof.
    Type: Application
    Filed: July 23, 2018
    Publication date: February 21, 2019
    Applicant: Vascular Biogenics Ltd.
    Inventors: Eyal Breitbart, Andrea Leubitz, Erez Feige, Richard Penson
  • FAS-chimera adenovirus vector
    Patent number: 9200056
    Abstract: The invention provides methods of reducing or decreasing a size of a tumor or eliminating a tumor or inhibiting, decreasing, or reducing neo-vascularization or angiogenesis in a tumor in a patient by administering an adenovirus comprising a nucleic acid construct comprising a FAS-chimera gene operably linked to an endothelial cell-specific promoter. Also provided is a homogeneous population of an adenovirus comprising a FAS-chimera gene operably linked to an endothelial cell-specific promoter and its uses thereof.
    Type: Grant
    Filed: October 29, 2014
    Date of Patent: December 1, 2015
    Assignee: Vascular Biogenics Ltd.
    Inventors: Eyal Breitbart, Andrea Leubitz, Erez Feige, Richard Penson
  • TREATMENT METHODS USING ADENOVIRUS
    Publication number: 20150044280
    Abstract: The invention provides methods of reducing or decreasing a size of a tumor or eliminating a tumor or inhibiting, decreasing, or reducing neo-vascularization or angiogenesis in a tumor in a patient by administering an adenovirus comprising a nucleic acid construct comprising a FAS-chimera gene operably linked to an endothelial cell-specific promoter. Also provided is a homogeneous population of an adenovirus comprising a FAS-chimera gene operably linked to an endothelial cell-specific promoter and its uses thereof.
    Type: Application
    Filed: October 29, 2014
    Publication date: February 12, 2015
    Applicant: Vascular Biogenics Ltd.
    Inventors: Eyal BREITBART, Andrea Leubitz, Erez Feige, Richard Penson